Precigen (PGEN) has a profit margin of -392.81%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for PGEN is -392.81% as of June 2026. That compares with -2868.66% in the prior-year period — up 86.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Precigen's historical trend and sector peers before judging valuation or financial health.
Over the past year, PGEN's profit margin moved from -2868.66% to -392.81% — a 86.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Precigen's valuation or profitability profile.
Against Healthcare companies, PGEN currently prints -392.81% for profit margin, while the sector average sits near 13.89%. That is roughly 2927.4% below the sector mean. Large gaps often invite a closer look at Precigen's growth, margins, and balance sheet.
Profit Margin shows how effectively Precigen converts resources into returns. At -392.81%, PGEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2868.66% in the prior-year period — up 86.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PGEN's profit margin (-392.81%), review year-over-year change from -2868.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.